THURSDAY, Sept. 19, 2024 -- A specific class of diabetes drug appears to lower people’s risk for dementia and Parkinson’s disease, a new study...
Vous n'êtes pas connecté
WEDNESDAY, Sept. 18, 2024 -- For patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitor (SGLT2i) use is associated with reduced risks for incident dementia and Parkinson disease (PD), according to a study published online Sept. 18...
THURSDAY, Sept. 19, 2024 -- A specific class of diabetes drug appears to lower people’s risk for dementia and Parkinson’s disease, a new study...
A recent study has revealed that certain medications used to treat type 2 diabetes may offer protection against dementia and Alzheimer’s disease...
TUESDAY, Sept. 17, 2024 -- For patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and diabetes, glucagon-like peptide 1...
TUESDAY, Sept. 17, 2024 -- Personality traits can influence cardiovascular disease (CVD) risk with type 2 diabetes mellitus (T2DM), according to a...
WEDNESDAY, Sept. 18, 2024 -- Greater Mediterranean-Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay (MIND) diet...
TUESDAY, Sept. 17, 2024 -- For postoperative patients with breast cancer, the duration of aromatase inhibitor (AI) treatment is not associated with...
Lower diligence in type 2 diabetes patients increases the risk of cardiovascular disease, but maintaining a healthy lifestyle is essential for...
FRIDAY, Sept. 13, 2024 -- Smoking cessation is associated with a reduced risk for atrial fibrillation (AF), according to a study published online...
The regular use of fish oil supplements and high circulating levels of Omega-3 polyunsaturated fatty acids (PUFAs), especially docosahexaenoic acid...
WEDNESDAY, Sept. 18, 2024 -- Habitual coffee or caffeine intake is associated with a lower risk for new-onset cardiometabolic multimorbidity (CM),...